Literature DB >> 29043409

Margin Width of Resected Lepidic Lung Cancer Does Not Affect Recurrence After Sublobar Resection.

Youngkyu Moon1, Kyo Young Lee2, Jae Kil Park3.   

Abstract

BACKGROUND: A sufficient resection margin is required for the sublobar resection of lung cancers. However, the width of the resection margin may not be important in lepidic adenocarcinoma, because such tumors are non- or minimally invasive. The purpose of this study was to determine the effect of resection margin width on the outcome of patients with lepidic-dominant adenocarcinoma after sublobar resection.
METHODS: This study included 133 patients with small (≤2 cm), clinical N0M0 lung cancer who underwent sublobar resection with curative intent. The patients were divided into 4 groups: Group A, lepidic tumor with margin/tumor ratio <1; Group B, lepidic tumor with margin/tumor ratio ≥1; Group C, non-lepidic tumor with margin/tumor ratio <1; Group D, non-lepidic tumor with margin/tumor ratio ≥1. The clinicopathological features and survival outcomes between Group A and B patients, and between Group C and D patients were compared.
RESULTS: The 5-year recurrence-free survival (RFS) rates of Group A and B patients were both 100%. The 5-year RFS rates of Group C and D patients were 49.9 and 97.1%, respectively (p = 0.009). By multivariate analysis, the margin/tumor ratio was a significant independent factor for recurrence in patients with non-lepidic tumors (hazard ratio = 0.157, 95% confidence interval 0.027-0.898; p = 0.037).
CONCLUSIONS: Tumor recurrence after sublobar resection is not associated with short resection margins in patients with lepidic tumors. However, a short resection margin is a significant risk factor for recurrence in patients with non-lepidic tumors.

Entities:  

Mesh:

Year:  2018        PMID: 29043409     DOI: 10.1007/s00268-017-4291-1

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  26 in total

Review 1.  Sublobar resection: a movement from the Lung Cancer Study Group.

Authors:  Justin D Blasberg; Harvey I Pass; Jessica S Donington
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

Review 2.  What is the most practical, optimal, and cost effective method for performing follow-up after lung cancer surgery, and by whom should it be done?

Authors:  Lise Tremblay; Jean Deslauriers
Journal:  Thorac Surg Clin       Date:  2013-06-28       Impact factor: 1.750

3.  A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L).

Authors:  Kenichi Nakamura; Hisashi Saji; Ryu Nakajima; Morihito Okada; Hisao Asamura; Taro Shibata; Shinichiro Nakamura; Hirohito Tada; Masahiro Tsuboi
Journal:  Jpn J Clin Oncol       Date:  2009-11-22       Impact factor: 3.019

4.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

5.  Pure ground-glass opacity on chest computed tomography: predictive factors for invasive adenocarcinoma.

Authors:  Youngkyu Moon; Sook Whan Sung; Kyo Young Lee; Sung Bo Sim; Jae Kil Park
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

6.  Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience.

Authors:  Junji Yoshida; Kanji Nagai; Tomoyuki Yokose; Mitsuyo Nishimura; Ryutaro Kakinuma; Hironobu Ohmatsu; Yutaka Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  2005-05       Impact factor: 5.209

7.  The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.

Authors:  Takashi Eguchi; Kyuichi Kadota; Bernard J Park; William D Travis; David R Jones; Prasad S Adusumilli
Journal:  Semin Thorac Cardiovasc Surg       Date:  2014-09-16

8.  Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.

Authors:  Jong Ho Cho; Yong Soo Choi; Jhingook Kim; Hong Kwan Kim; Jae Ill Zo; Young Mog Shim
Journal:  Ann Thorac Surg       Date:  2014-11-15       Impact factor: 4.330

9.  Clinicopathologic Factors Associated With Occult Lymph Node Metastasis in Patients With Clinically Diagnosed N0 Lung Adenocarcinoma.

Authors:  Youngkyu Moon; Kyung Soo Kim; Kyo Young Lee; Sook Whan Sung; Young Kyoon Kim; Jae Kil Park
Journal:  Ann Thorac Surg       Date:  2016-03-05       Impact factor: 4.330

10.  Wedge resection margin distances and residual adenocarcinoma in lobectomy specimens.

Authors:  Neal S Goldstein; Monica Ferkowicz; Larry Kestin; Gary W Chmielewski; Robert J Welsh
Journal:  Am J Clin Pathol       Date:  2003-11       Impact factor: 2.493

View more
  4 in total

Review 1.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 2: systematic review of evidence regarding resection extent in generally healthy patients.

Authors:  Frank C Detterbeck; Vincent J Mase; Andrew X Li; Ulas Kumbasar; Brett C Bade; Henry S Park; Roy H Decker; David C Madoff; Gavitt A Woodard; Whitney S Brandt; Justin D Blasberg
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

2.  Does surgical margin affect recurrence and survival after sublobar pulmonary resection for lung cancer?

Authors:  Weijing Liu; Hongjin Lai; Zihuai Wang; Lunxu Liu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-01

3.  Prognosis after wedge resection in patients with 8th edition TNM stage IA1 and IA2 non-small cell lung cancer.

Authors:  Youngkyu Moon; Jae Kil Park; Kyo Young Lee; Eun Sung Kim
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

4.  The prognosis of small-sized non-small cell lung cancer with visceral pleural invasion after sublobar resection.

Authors:  Si Young Choi; Mi Hyoung Moon; Youngkyu Moon
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.